Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

European Patient Summary

Patient
Name: Kubíčková, , Hynek,
DOB: 24-JUN-2005 (Age: 20)
Gender: male
ID: 9771-756399-9 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 06-OCT-2022

Problem list

No known problems or disabilities

Medication list

Medication Since Form Dosage Reason
Fexofenadine hydrochloride 30 mg oral tablet 2001-03-17 - 1 tablet (30 mg) twice daily -
Epinephrine 1 mg/mL solution for injection 2001-03-17 - 0.3 mg (1:1000) IM every 5 to 15 minutes as needed -

Immunizations list

Vaccine Date
Hepatitis B virus antigen only vaccine product 06-Oct-2022
Clostridium tetani toxoid antigen adsorbed only vaccine product 06-Oct-2022
Neisseria meningitidis antigen-containing vaccine product 06-Oct-2022
Influenza virus antigen only vaccine product 06-Oct-2022
SARS-CoV-2 mRNA vaccine 13-May-2021

Procedure History list

Procedure Date Reason
Medication reconciliation 22-Sep-2016 -
Depression screening 21-Apr-2016 -
Anticipatory guidance 21-Apr-2016 -
Assessment of anxiety 21-Apr-2016 -
Depression screening using PHQ-9 (Patient Health Questionnaire 9) score 21-Apr-2016 -
Assessment using Car 21-Apr-2016 -
Assessment of substance use 21-Apr-2016 -

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
Aspirin 2001-03-17 active medication Abdominal pain (finding)
Mold 2001-03-17 active environment
Eggs (edible) 2001-03-17 active food Wheal (finding)
Latex 2001-03-17 active environment Wheal (finding)
Grass pollen 2001-03-17 active environment
House dust mite 2001-03-17 active environment
Animal dander 2001-03-17 active environment Rhinoconjunctivitis (disorder)
Wheal (finding)
Allergy to substance 2001-03-17 active environment
Fish 2001-03-17 active food Dyspnea (finding)
Eruption of skin (disorder)
Tree pollen 2001-03-17 active environment

Care Plan

Active Planned Care / Goals Start Date Reason
Self-care interventions 05-Mar-2001 -

Vital Signs

Vital Signs 2022-10-06 2020-07-17
Body Height 188.5 cm -
Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score} -
Body Weight 88.1 kg 84.4 kg
Body mass index (BMI) [Ratio] 24.8 kg/m2 -
Diastolic Blood Pressure 88 mm[Hg] 86 mm[Hg]
Systolic Blood Pressure 110 mm[Hg] 113 mm[Hg]
Heart rate 83 /min 178.2 /min
Respiratory rate 14 /min 26.4 /min
Body temperature - 41.7 Cel
Oxygen saturation in Arterial blood - 84.8 %

Relevant diagnostic tests/laboratory data

Recent Lab Observations 06-OCT-2022 Reference Range Unit
Leukocytes [#/volume] in Blood by Automated count 8.2 3.5 - 10.5 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 4.0 L 4.5 - 6.2 10*6/uL
Hemoglobin [Mass/volume] in Blood 16.0 14 - 18 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 48.7 38 - 52 %
MCV [Entitic volume] by Automated count 86.5 80 - 98 fL
MCH [Entitic mass] by Automated count 29.8 27 - 33 pg
MCHC [Mass/volume] by Automated count 33.8 32 - 36 g/dL
Erythrocyte distribution width [Entitic volume] by Automated count 45.7 36 - 55 fL
Platelets [#/volume] in Blood by Automated count 251.7 150 - 350 10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count 377.3 150 - 450 fL
Platelet mean volume [Entitic volume] in Blood by Automated count 11.8 9.8 - 13.8 fL